MedPAC examines Medicare quality measurement, drug spending
At meetings this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
David Stark, chief of government and external affairs and philanthropy officer at UnityPoint Health, shares how a major philanthropic investment is helping…
Headline
The AHA announced April 13 that Deborah Bowen, president and CEO of the American College of Healthcare Executives, along with four retiring state hospital…
Headline
The AHA April 13 provided comments to the Department of Health and Human Services on the U.S. Core Data for Interoperability Draft Version 7, a standardized…
Chairperson's File
More than 1,000 leaders from hospitals and health systems across the country will gather in Washington, D.C., early next week at the 2026 AHA Annual…
Headline
The Centers for Medicare & Medicaid Services April 10 released a proposed rule that would establish electronic standards for drug prior authorizations.…
Headline
Health care and public health was the top sector targeted for cyberthreats in 2025, according to the FBI’s latest annual report on internet crimes. There were…